Search
Back 

NRG-GI001

NRG-GI001: Randomized Phase III Study of Focal Radiation Therapy for Unresectable, Localized Intrahepatic Cholangiocarcinoma

View Press Release

View PowerPoint Presentation

Principal Investigator

Theodore Hong, MD

Primary Objective

To evaluate liver-directed radiation therapy with respect to overall survival (OS) for patients with unresectable, localized intrahepatic cholangiocarcinoma.

Patient Population

Pathologically (histologically or cytologically) proven diagnosis of IHC without distant extrahepatic metastasis

Target Accrual

146

Status

Activated:9/29/2014 

Protocol Documents

Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website

Copyright 2017 by NRG Oncology